Hyperammonemia: Difference between revisions
Brian Blank (talk | contribs) No edit summary |
Kiran Singh (talk | contribs) No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 12: | Line 12: | ||
MeshID = D022124 | | MeshID = D022124 | | ||
}} | }} | ||
__Notoc__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | ==Overview== | ||
'''Hyperammonemia''' (or 'hyperammonaemia') is a metabolic disturbance characterised by an excess of [[ammonia]] in the blood. It is a dangerous condition that may lead to [[encephalopathy]] and death. It may be primary or secondary. | '''Hyperammonemia''' (or 'hyperammonaemia') is a metabolic disturbance characterised by an excess of [[ammonia]] in the blood. It is a dangerous condition that may lead to [[encephalopathy]] and death. It may be primary or secondary. | ||
| Line 38: | Line 39: | ||
==Sequelae== | ==Sequelae== | ||
Hyperammonemia is one of the metabolic derangements that contribute to [[hepatic encephalopathy]]. | Hyperammonemia is one of the metabolic derangements that contribute to [[hepatic encephalopathy]]. | ||
==Causes== | |||
* Drug side effects: [[Glycerol phenylbutyrate]] | |||
==See also== | ==See also== | ||
| Line 53: | Line 57: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Latest revision as of 19:11, 28 April 2015
| Hyperammonemia | |
| ICD-10 | E72.2 |
|---|---|
| ICD-9 | 270.6 |
| DiseasesDB | 20468 |
| eMedicine | neuro/162 ped/1057 |
| MeSH | D022124 |
|
WikiDoc Resources for Hyperammonemia |
|
Articles |
|---|
|
Most recent articles on Hyperammonemia Most cited articles on Hyperammonemia |
|
Media |
|
Powerpoint slides on Hyperammonemia |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Hyperammonemia at Clinical Trials.gov Trial results on Hyperammonemia Clinical Trials on Hyperammonemia at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Hyperammonemia NICE Guidance on Hyperammonemia
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Hyperammonemia Discussion groups on Hyperammonemia Patient Handouts on Hyperammonemia Directions to Hospitals Treating Hyperammonemia Risk calculators and risk factors for Hyperammonemia
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Hyperammonemia |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Hyperammonemia (or 'hyperammonaemia') is a metabolic disturbance characterised by an excess of ammonia in the blood. It is a dangerous condition that may lead to encephalopathy and death. It may be primary or secondary.
Ammonia is a substance that contains nitrogen. It is a product of the catabolism of protein. It is converted to the non-toxic substance urea prior to excretion in urine by the kidneys. The metabolic pathways that synthesise urea are located first in the mitochondria and then into the cytosol. The process is known as the urea cycle, which comprises several enzymes acting in sequence.
Types
Primary vs. secondary
- Primary hyperammonemia is caused by several inborn errors of metabolism that are characterised by reduced activity of any of the enzymes in the urea cycle.
- Secondary hyperammonemia is caused by inborn errors of intermediary metabolism characterised by reduced activity in enzymes that are not part of the urea cycle (e.g .Propionic acidemia, Methylmalonic acidemia) or dysfunction of cells that make major contributions to metabolism (eg hepatic failure).
Specific types
In all cases Hyperammonemia results from defects of the Urea cycle. The following list includes such examples:
- Online Mendelian Inheritance in Man (OMIM) 311250 - hyperammonemia due to ornithine transcarbamylase deficiency
- Online Mendelian Inheritance in Man (OMIM) 606762 - hyperinsulinism-hyperammonemia syndrome (glutamate dehydrogenase 1)
- Online Mendelian Inheritance in Man (OMIM) 238970 - hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (ornithine translocase)
- Online Mendelian Inheritance in Man (OMIM) 237310 - hyperammonemia due to N-acetylglutamate synthetase deficiency
- Online Mendelian Inheritance in Man (OMIM) 237300 - hyperammonemia due to carbamoyl phosphate synthetase i deficiency (carbamoyl phosphate synthase I)
- Online Mendelian Inheritance in Man (OMIM) 238750 - hyperlysinuria with hyperammonemia (genetics unknown)
Sequelae
Hyperammonemia is one of the metabolic derangements that contribute to hepatic encephalopathy.
Causes
- Drug side effects: Glycerol phenylbutyrate